lifestyle.thenyctimes.com

Author: Viva Biotech

Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

March 30, 2026
Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the ‘Lab-in-the-Loop’ with NVIDIA

March 16, 2026
Adventures in DMPK: Viva Biotech’s One-Stop Pharmacology Platform Cross New Modalities

December 29, 2025
Viva Biotech’s invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

December 15, 2025